{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:28:26Z","timestamp":1786768106415,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32570817"],"award-info":[{"award-number":["32570817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32400697"],"award-info":[{"award-number":["32400697"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377060"],"award-info":[{"award-number":["22377060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2023YFA1801200"],"award-info":[{"award-number":["2023YFA1801200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1801200"],"award-info":[{"award-number":["2023YFA1801200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202312240"],"award-info":[{"award-number":["tsqn202312240"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jare.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:47:05Z","timestamp":1786117625000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel flavonoid derivative for treating colorectal cancer by suppressing tumor angiogenesis through VEGFR2 inhibition"],"prefix":"10.1016","author":[{"given":"Kun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xushan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changliang","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2026.08.005_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J Clinicians"},{"key":"10.1016\/j.jare.2026.08.005_b0010","article-title":"Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation","volume":"6","author":"Ma","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2026.08.005_b0015","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1111\/bph.13966","article-title":"Melatonin: does it have utility in the treatment of haematological neoplasms?","volume":"175","author":"Li","year":"2017","journal-title":"British J Pharmacol"},{"key":"10.1016\/j.jare.2026.08.005_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684807","article-title":"The regulatory network and potential role of LINC00973-miRNA-mRNA ceRNA in the progression of non-small-cell lung cancer","volume":"12","author":"Guo","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2026.08.005_b0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.08.005_b0030","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.jare.2026.08.005_b0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","article-title":"Drug repurposing for cancer therapy","volume":"9","author":"Xia","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jare.2026.08.005_b0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43556-024-00239-2","article-title":"Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer","volume":"6","author":"Gu","year":"2025","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.jare.2026.08.005_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.32604\/or.2023.028657","article-title":"Macrophage-derived SHP-2 inhibits the metastasis of colorectal cancer via Tie2-PI3K signals","volume":"31","author":"Wu","year":"2023","journal-title":"Oncology Res"},{"key":"10.1016\/j.jare.2026.08.005_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-12508-y","article-title":"Mindfulness intervention, homogeneous medical concept, and concentrated solution nursing for colorectal cancer patients: a retrospective study","volume":"24","author":"Feng","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2026.08.005_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.935500","article-title":"Clinical significance of serum haptoglobin and protein disulfide-isomerase A3 in the screening, diagnosis, and staging of colorectal cancer","volume":"13","author":"Niu","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2026.08.005_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.750948","article-title":"Three-dimensionally printed Ti2448 with low stiffness enhanced angiogenesis and osteogenesis by regulating macrophage polarization via Piezo1\/YAP signaling axis","volume":"9","author":"Tang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jare.2026.08.005_b0065","article-title":"An integrated smart sensor dressing for real-time wound microenvironment monitoring and promoting angiogenesis and wound healing","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jare.2026.08.005_b0070","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8301888","article-title":"m6A\u2010related angiogenic genes to construct prognostic signature, reveal immune and oxidative stress landscape, and screen drugs in hepatocellular carcinoma","volume":"2022","author":"Qu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jare.2026.08.005_b0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.08.005_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-024-01014-9","article-title":"Vascular galectins in tumor angiogenesis and cancer immunity","volume":"46","author":"Thijssen","year":"2024","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jare.2026.08.005_b0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10456-024-09913-z","article-title":"Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism","volume":"27","author":"Yang","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jare.2026.08.005_b0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40364-025-00779-x","article-title":"Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies","volume":"13","author":"Liu","year":"2025","journal-title":"Biomarker Res"},{"key":"10.1016\/j.jare.2026.08.005_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118023","article-title":"Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: Therapeutic strategies and insights","volume":"186","author":"Mahaki","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2026.08.005_b0100","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.7150\/thno.113665","article-title":"Breaking the premetastatic niche barrier: the role of endothelial cells and therapeutic strategies","volume":"15","author":"Fang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jare.2026.08.005_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2025.101611","article-title":"Endothelial cell in tumor angiogenesis: origins, mechanisms, and therapeutic implication","volume":"12","author":"Han","year":"2025","journal-title":"Genes & Diseases"},{"key":"10.1016\/j.jare.2026.08.005_b0110","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.cell.2026.03.016","article-title":"Targeting angiogenesis: lessons from 25 years of normalizing tumor vasculature","volume":"189","author":"Subudhi","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.jare.2026.08.005_b0115","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor A","volume":"24","author":"P\u00e9rez-Guti\u00e9rrez","year":"2023","journal-title":"Nat Rev Molecular Cell Biol"},{"key":"10.1016\/j.jare.2026.08.005_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02249-0","article-title":"Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.jare.2026.08.005_b0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-022-01310-7","article-title":"Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy","volume":"15","author":"Liu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jare.2026.08.005_b0130","doi-asserted-by":"crossref","first-page":"12651","DOI":"10.1021\/acs.jmedchem.2c01737","article-title":"Is target-based drug discovery efficient? discovery and \u201coff-target\u201d mechanisms of all drugs","volume":"66","author":"Sadri","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2026.08.005_b0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.semcancer.2022.03.003","article-title":"Promalignant effects of antiangiogenics in the tumor microenvironment","volume":"86","author":"Peix","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jare.2026.08.005_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100849","article-title":"New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects","volume":"64","author":"Huang","year":"2022","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jare.2026.08.005_b0145","doi-asserted-by":"crossref","first-page":"18522","DOI":"10.1021\/jacs.0c07490","article-title":"Bicyclobutane carboxylic amide as a cysteine-directed strained electrophile for selective targeting of proteins","volume":"142","author":"Tokunaga","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jare.2026.08.005_b0150","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1038\/s41467-024-52573-2","article-title":"Reversible covalent c-Jun N-terminal kinase inhibitors targeting a specific cysteine by precision-guided Michael-acceptor warheads","volume":"15","author":"B\u00e1lint","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2026.08.005_b0155","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41564-020-0745-6","article-title":"Targeting the trypanosome kinetochore with CLK1 protein kinase inhibitors","volume":"5","author":"Saldivia","year":"2020","journal-title":"Nature Microbiol"},{"key":"10.1016\/j.jare.2026.08.005_b0160","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3390\/ijms27083605","article-title":"Flavonoids as inhibitors of VEGFR2 signaling: structural insights for the development of safer anti-angiogenic therapies","volume":"27","author":"Yim","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.08.005_b0165","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/molecules29071570","article-title":"Flavonoids with anti-angiogenesis function in cancer","volume":"29","author":"Wei","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2026.08.005_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2026.118043","article-title":"Traditional Chinese medicine targets vascular endothelial growth factor receptor 2 to treat retinal neovascularization","volume":"250","author":"Dai","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jare.2026.08.005_b0175","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1021\/jm040770b","article-title":"Effects of flavonoids on cell proliferation and caspase activation in a human colonic cell line HT29: an SAR study","volume":"48","author":"Daskiewicz","year":"2005","journal-title":"J Medicinal Chem"},{"key":"10.1016\/j.jare.2026.08.005_b0180","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1016\/j.ejmech.2010.06.025","article-title":"Prenylflavonoids and prenyl\/alkyl-phloroacetophenones: synthesis and antitumour biological evaluation\u2606","volume":"45","author":"Basabe","year":"2010","journal-title":"Eur J Medicinal Chem"},{"key":"10.1016\/j.jare.2026.08.005_b0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.08.005_b0190","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14756366.2021.2015343","article-title":"New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies","volume":"37","author":"Elkady","year":"2021","journal-title":"J Enzyme Inhibition and Medicinal Chem"},{"key":"10.1016\/j.jare.2026.08.005_b0195","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/biom14020218","article-title":"Discovery of a novel series of quinazoline-thiazole hybrids as potential antiproliferative and anti-angiogenic agents","volume":"14","author":"\u0218andor","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jare.2026.08.005_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/ph15111416","article-title":"Design, synthesis, molecular modeling, and anticancer evaluation of new VEGFR-2 inhibitors based on the indolin-2-one scaffold","volume":"15","author":"Abdelgawad","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jare.2026.08.005_b0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13065-025-01459-5","article-title":"Synthesis of thiazoloquinolinone derivatives: molecular docking, MD simulation, and pharmacological evaluation as VEGFR-2 inhibitors","volume":"19","author":"Amiri","year":"2025","journal-title":"BMC Chem"},{"key":"10.1016\/j.jare.2026.08.005_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2021.105621","article-title":"Evaluation of ponatinib in vitro effect in three canine mast cell tumor cell lines expressing FGFR-1, PDGFR-\u03b1, and VEGFR-2","volume":"269","author":"Fisher","year":"2021","journal-title":"Vet J"},{"key":"10.1016\/j.jare.2026.08.005_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112922","article-title":"The multi-targeted tyrosine kinase inhibitor SKLB610 resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs","volume":"149","author":"Wu","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2026.08.005_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27533","article-title":"Flavonoids: a treasure house of prospective pharmacological potentials","volume":"10","author":"Hasnat","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jare.2026.08.005_b0225","first-page":"658","article-title":"Flavonoids in medicine and food homology substances: structure\u2013activity relationship","volume":"15","author":"Wang","year":"2026","journal-title":"Application Challenges, and Cutting-Edge Technol Breakthroughs Foods"},{"key":"10.1016\/j.jare.2026.08.005_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1033003","article-title":"Michael acceptor molecules in natural products and their mechanism of action","volume":"13","author":"Liang","year":"2022","journal-title":"Frontiers in Pharmacol"},{"key":"10.1016\/j.jare.2026.08.005_b0235","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.3390\/ijms25116099","article-title":"Michael acceptors as anti-cancer compounds: coincidence or causality?","volume":"25","author":"Andr\u00e9s","year":"2024","journal-title":"Int J Molecular Sci"},{"key":"10.1016\/j.jare.2026.08.005_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2022.100100","article-title":"Chalcone: a potential scaffold for NLRP3 inflammasome inhibitors","volume":"7","author":"Thapa","year":"2023","journal-title":"Eur J Medicinal Chem Reports"},{"key":"10.1016\/j.jare.2026.08.005_b0245","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s11030-024-10965-y","article-title":"Gene network analysis combined with preclinical studies to identify and elucidate the mechanism of action of novel irreversible Keap1 inhibitor for Parkinson\u2019s disease","volume":"29","author":"Arumugam","year":"2024","journal-title":"Mol Divers"},{"issue":"2013","key":"10.1016\/j.jare.2026.08.005_b0250","first-page":"173","article-title":"Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance","volume":"111","author":"Schwartz","year":"2013","journal-title":"Proc Natl Acad Sci"},{"issue":"2011","key":"10.1016\/j.jare.2026.08.005_b0255","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1073\/pnas.1111239108","article-title":"Chemical genetic strategy for targeting protein kinases based on covalent complementarity","volume":"108","author":"Garske","year":"2011","journal-title":"Proc Natl Acad Sci"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226006144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226006144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:06:35Z","timestamp":1786766795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226006144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S2090123226006144"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.08.005","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel flavonoid derivative for treating colorectal cancer by suppressing tumor angiogenesis through VEGFR2 inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}